{
    "applicationNumber": "BR 11 2022 013292-1",
    "filingDate": "19/01/2021",
    "grantDate": null,
    "title": "COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA CONTENDO ANTICORPO ANTI-BTLA E USO DA MESMA",
    "nationalPhaseDate": [
        "01/07/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT CN2021/072660",
        "pctDate": "19/01/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "CN",
            "priorityNumber": "202010066932.1",
            "priorityDate": "20/01/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2688"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2696"
        }
    ],
    "inventors": [
        "HONGCHUAN LIU",
        "PEIXIANG LIU",
        "JING ZHANG",
        "YUEHUA ZHOU",
        "HUI LIU",
        "XUERU CHEN",
        "JING WANG",
        "HUI FENG",
        "SHENG YAO"
    ],
    "holders": [
        248669,
        248670
    ],
    "ipcCodes": [
        "A61K 39/395",
        "A61P 37/06",
        "C07K 16/28"
    ]
}